From the *Department of Nuclear Medicine, University Hospital, LMU Munich;
†German Cancer Consortium (DKTK), partner site Munich, Munich;
‡German Cancer Research Center (DKFZ), Heidelberg; and
§Department of Neuropathology,
∥Institute of Clinical Neuroimmunology, and
¶Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany.
Received for publication June 18, 2018; revision accepted July 20, 2018.
Conflicts of interest and sources of funding: none declared.
Correspondence to: Marcus Unterrainer, MD, MSc, Department of Nuclear Medicine University Hostpital, LMU Munich Marchioninistr. 15, 81377 Munich, Germany. E-mail: [email protected].
